Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 2Plasma cell 1Other 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 1Dyspnea 1Cardiotoxicity 1

Interventions

tegaserod 3naloxegol 3Radiotherapy 3Cisplatin 3Surveys and Questionnaires 2Radiation 2Lidocaine 2prucalopride 1pegfilgrastim 1oxycodone naloxone combination 1indole-3-carbinol 1hydrated silica gel-based toothpaste 1glucarpidase 1angiotensin I (1-7) 1alvimopan 1aluminum hydroxide, magnesium hydroxide, drug combination 1Vitamin D 1Transcutaneous Electric Nerve Stimulation 1Thyrotropin-Releasing Hormone 1Tablets 1Surgical Procedures, Operative 1Sennosides 1Selenomethionine 1Phenolphthalein 1Observation 1Nutrition Assessment 1Neck Dissection 1Methotrexate 1Methods 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hematologic Tests × Other × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡